Identification of neonatal haemolysis: an approach to predischarge management of neonatal hyperbilirubinemia

被引:26
|
作者
Bhutani, Vinod K. [1 ]
Srinivas, Shanmukha [1 ]
Cuadrado, Martin E. Castillo [1 ]
Aby, Janelle L. [2 ]
Wong, Ronald J. [1 ]
Stevenson, David K. [1 ]
机构
[1] Stanford Univ, Dept Pediat, Sch Med, Div Neonatal & Dev Med, Stanford, CA 94305 USA
[2] Stanford Univ, Div Gen Pediat, Sch Med, Stanford, CA 94305 USA
关键词
Bilirubin; Bilirubin elimination; Bilirubin production; End-tidal carbon monoxide; Newborn jaundice; TIDAL CARBON-MONOXIDE; BILIRUBIN PRODUCTION; PULMONARY EXCRETION; NEAR-TERM; INFANTS; RISK; PREDICTION; JAUNDICE; INDEX;
D O I
10.1111/apa.13341
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
AimRelative contributions of increased production [by end-tidal carbon monoxide concentrations (ETCOc)] and decreased elimination of bilirubin to predischarge hour-specific total bilirubin (TB) levels were assessed in healthy late-preterm and term newborns. Secondly, we report predischarge ETCOc ranges to guide clinical management of hyperbilirubinemia. MethodsTB and ETCOc (3 timepoints) determinations of newborns aged between six hours and <6 days (n = 79) were stratified by postnatal age epochs. Hyperbilirubinemia risk was assessed by plotting TB values as a function of ETCOc. ResultsStratifications of ETCOc (in ppm, mean, median and interquartile ranges) by postnatal age epochs (0-24, 24-48 and 48-72) were as follows: 2.0, 1.9, 1.8-2.2 (n = 11); 1.6, 1.5, 1.1-2.0 (n = 58); and 2.0, 1.8, 1.6-2.3 (n = 9), respectively. Infants with ETCOc 2.5 were at high risk, between 1.5 and 2.5 at moderate risk and 1.5 were at low risk. Risk due to haemolysis alone was not independent (p < 0.01). For infants with TB >75th percentile (n = 31), 23% had ETCO 1.5, and 77% had ETCOc > 1.5 (p < 0.00003). ConclusionNear-simultaneous ETCOc and TB measurements in infants with TB >75th percentile accurately identify haemolytic hyperbilirubinemia.
引用
收藏
页码:E189 / E194
页数:6
相关论文
共 50 条
  • [41] PHOTOTHERAPY IN NEONATAL HYPERBILIRUBINEMIA
    JOHN, E
    [J]. AUSTRALIAN PAEDIATRIC JOURNAL, 1973, 9 (04): : 215 - 215
  • [42] STUDY OF NEONATAL HYPERBILIRUBINEMIA
    ZEIS, PM
    [J]. IRISH MEDICAL JOURNAL, 1974, 67 (21) : 568 - 570
  • [43] SEASONAL NEONATAL HYPERBILIRUBINEMIA
    MILBY, TH
    MITCHELL, JE
    FREEMAN, TS
    [J]. PEDIATRICS, 1969, 43 (4P1) : 601 - &
  • [44] EPIDEMIOLOGY OF NEONATAL HYPERBILIRUBINEMIA
    LAU, SP
    FUNG, KP
    FOK, TF
    [J]. PEDIATRICS, 1985, 76 (06) : 1017 - 1018
  • [45] Hyperbilirubinemia and Neonatal Infection
    Maamouri, Gholamali
    Khatami, Fatemah
    Mohammadzadeh, Ashraf
    Saeidi, Reza
    Farhat, Ahmad shah
    Kiani, Mohammad Ali
    Boskabadi, Hassan
    [J]. INTERNATIONAL JOURNAL OF PEDIATRICS-MASHHAD, 2013, 1 (01): : 5 - 12
  • [46] PHOTOTHERAPY FOR NEONATAL HYPERBILIRUBINEMIA
    POLAND, RL
    [J]. PEDIATRICS, 1986, 78 (01) : 179 - 180
  • [47] Clofibrate in Neonatal Hyperbilirubinemia
    Deepak Chawla
    [J]. The Indian Journal of Pediatrics, 2017, 84 : 735 - 736
  • [48] ANTIBIOTICS AND NEONATAL HYPERBILIRUBINEMIA
    ROMAGNOLI, C
    MASTRANGELO, R
    STABILE, A
    GIORDANO, P
    [J]. LANCET, 1974, 2 (7875): : 295 - 295
  • [49] PHOTOTHERAPY FOR NEONATAL HYPERBILIRUBINEMIA
    ZACHMAN, RD
    [J]. JOURNAL OF PEDIATRICS, 1973, 83 (04): : 690 - 691
  • [50] Perspective on Neonatal Hyperbilirubinemia
    Sheriff, Dhastagir Sultan
    Jarari, Abdalla M.
    [J]. INTERNET JOURNAL OF MEDICAL UPDATE, 2011, 6 (01) : 44 - 50